CMS To Help Build National FDG-PET Cancer Registry, Will Cover Trials

CMS plans to work with stakeholders to develop a national registry as well as small studies to determine the clinical utility of FDG-PET in the management of brain, ovarian, pancreatic and small-cell lung cancers